| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/10/2009 | US20090227612 Aminopyrimidine Derivatives Inhibiting Protein Kinase Activity, Method For The Preparation Thereof And Pharmaceutical Composition Containing Same |
| 09/10/2009 | US20090227608 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 09/10/2009 | US20090227598 Ret Tyrosine Kinase Inhibition |
| 09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |
| 09/10/2009 | US20090227579 Pteridine Derivatives and their Use as Cathespin Inhibitors |
| 09/10/2009 | US20090227575 7H-PYRROLO[2,3-H]QUINAZOLINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS |
| 09/10/2009 | US20090227574 Administration of Carboline Derivatives Useful in the Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090227561 Fused heterocyclic derivative and use thereof |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227556 Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives |
| 09/10/2009 | US20090227542 Novel Boronic Chalcone Derivatives and Uses Thereof |
| 09/10/2009 | US20090227533 miR-34 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 09/10/2009 | US20090227529 Combination treatment for bladder cancer |
| 09/10/2009 | US20090227524 Antiviral therapeutic agents |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227510 Induction of tumor immunity by variants of folate binding protein |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227490 Antitumoral Treatments |
| 09/10/2009 | US20090227012 Nucleotide sequences coding modified immunoglobulin for use in prevention and treatment of cancer and/or inflammatory disease |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226942 Modified aerolysin and methods of use for treating lung cancer |
| 09/10/2009 | US20090226936 Tetrahydrofolate Synthetase Gene |
| 09/10/2009 | US20090226539 Treatment of Ovarian Cancer |
| 09/10/2009 | US20090226538 Anticancer or antiviral composition |
| 09/10/2009 | US20090226526 Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 09/10/2009 | US20090226525 Self-assembling nanoparticle drug delivery system |
| 09/10/2009 | US20090226512 Methods and Compositions for Oral Delivery of FTS |
| 09/10/2009 | US20090226508 Methods And Materials For Immunization Against Cancer |
| 09/10/2009 | US20090226484 Immunogenic LHRH compositions and methods relating thereto |
| 09/10/2009 | US20090226473 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 09/10/2009 | US20090226466 Therapeutic anti-her2 antibody fusion polypeptides |
| 09/10/2009 | US20090226455 Combination therapy with c-met and her antagonists |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226447 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 09/10/2009 | US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea |
| 09/10/2009 | US20090226435 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases |
| 09/10/2009 | US20090226431 Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/10/2009 | US20090226422 Chemical Inhibitors of Inhibitors of Differentiation |
| 09/10/2009 | US20090226411 Chemical derivatives and their application as antitelomerase agents |
| 09/10/2009 | US20090226399 Medicaments comprising gene recombinant antibody against ganglioside gd3 |
| 09/10/2009 | US20090226396 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| 09/10/2009 | US20090226395 Pharmaceutical compositions of beta-lapachone and beta-lapachone analogs with improved tumor targeting potential |
| 09/10/2009 | US20090226393 Polymer paclitaxel conjugates and methods for treating cancer |
| 09/10/2009 | US20090226372 Methods and compositions related to peptides and proteins with c-terminal elements |
| 09/10/2009 | US20090226369 STQ Peptides |
| 09/10/2009 | US20090226368 Androgen-Receptor (AR) Ligands for Use in the Treatment and Diagnosis of AR-Related Pathologies |
| 09/10/2009 | DE20321763U1 Synergistisch wirkende Kombination von Phenylbutyrat und Aminobenzoesäure zur Krebstherapie Synergistic combination of phenylbutyrate and aminobenzoic acid for cancer therapy |
| 09/10/2009 | DE202009007345U1 Neue Pharmazeutika und Arzneimittelzubereitungen New pharmaceuticals and pharmaceutical preparations |
| 09/09/2009 | EP2098598A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 09/09/2009 | EP2098595A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 09/09/2009 | EP2098593A1 hTERT expression regulatory gene |
| 09/09/2009 | EP2098589A2 Immune cell modification method and cell modification device |
| 09/09/2009 | EP2098534A1 Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
| 09/09/2009 | EP2098533A1 Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
| 09/09/2009 | EP2098521A1 Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation |
| 09/09/2009 | EP2098514A1 Preparation of compounds useful for the detection of hypoxia |
| 09/09/2009 | EP2098236A1 Cytostatic compositions |
| 09/09/2009 | EP2097534A2 Human antibodies that bind cd70 and uses thereof |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097414A1 Pyrrolo [2, 3-b]pyridine derivatives as kinase modulators |
| 09/09/2009 | EP2097409A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 09/09/2009 | EP2097394A1 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 09/09/2009 | EP2097393A1 Therapeutic g-quadruplex ligands |
| 09/09/2009 | EP2097392A1 1,2,3-triazole derivatives as sigma receptor inhibitors |
| 09/09/2009 | EP2097386A2 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 09/09/2009 | EP2097384A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 09/09/2009 | EP2097381A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenox]-n-methylpyridine-2-carboxamide monohydrate |
| 09/09/2009 | EP2097139A1 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n,n',n'-tetrakis(2 -chloroethyl)phosphorodiamidates |
| 09/09/2009 | EP2097111A2 Heterodimers of glutamic acid |
| 09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 09/09/2009 | EP2097098A1 Expression of transgenic t cell receptors in lak-t cells |
| 09/09/2009 | EP2097097A2 Human antibodies that bind cd22 and uses thereof |
| 09/09/2009 | EP2097080A2 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 09/09/2009 | EP2097078A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 09/09/2009 | EP2096924A1 Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents |
| 09/09/2009 | EP2096917A2 Cyclopamine analogs |
| 09/09/2009 | EP1556398B1 Novel cytarabine monophosphate prodrugs |
| 09/09/2009 | EP1553923B1 Camptothecin-carboxylate formulations |
| 09/09/2009 | EP1548028B1 Substituted type peptides of wt1 |
| 09/09/2009 | EP1519724B1 Fredericamycin derivatives as medicaments for treating tumours |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
| 09/09/2009 | EP1453848A4 Sir2 products and activities |
| 09/09/2009 | EP1397355B1 Pyridyl cyanoguanidine compounds |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | EP1098962B1 Diacylglycerol acyl transferase proteins |
| 09/09/2009 | EP1061915A4 Pharmaceutical formulations of taxanes |
| 09/09/2009 | EP1033971B1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | EP0771147B1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/09/2009 | CN101528309A Methods for treating cancer comprising the administration of a vitamin D compound and an additional therapeutic agent |
| 09/09/2009 | CN101528308A Methods and compositions for treating cancer |